Terpos, E., Ntanasis-Stathopoulos, I., Gavriatopoulou, M., Kanellias, N., Malandrakis, P., Solia, E., Theodorakakou, F., Vasalou, E., Migkou, M., Papaiakovou, E. E., Kastritis, E., Dimopoulos, M. A. (2026). Belantamab mafodotin with daratumumab, lenalidomide, and dexamethasone in transplant-ineligible, newly diagnosed multiple myeloma patients: Phase 1/2 BelaDRd study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.7512